Department of Epidemiology, Columbia University man School of Public Health, New York, NY, United States; New York State Psychiatric Institute, New York, NY, United States.
Department of Psychiatry, Dartmouth Geisel School of Medicine, One Medical Center Drive, Lebanon, NH, United States.
Addict Behav. 2022 Oct;133:107374. doi: 10.1016/j.addbeh.2022.107374. Epub 2022 May 23.
Use of novel cannabis products whose primary active compound is Delta-8 tetrahydrocannabinol (Delta-8 THC), an isomer of Delta-9 THC has recently surged. While Delta-8 THC has psychoactive effects and is potentially harmful, little is known about its use. We examined sociodemographic characteristics, motivations, and consumption patterns of Delta-8 THC in US adult cannabis users.
Cannabis-using adult online survey participants (N = 4,348) provided information on Delta-8 use, and other characteristics. We assessed frequencies of sociodemographics, patterns, and correlates of Delta-8 THC use. Regression models estimated adjusted odds ratios (aOR) and 95% confidence intervals (CI) of associations between past 30-day Delta-8 THC use, sociodemographic and other characteristics.
Among past 30-day cannabis users, 16.7% reported Delta-8 THC use. The most common consumption method was vaping concentrated formulations of Delta-8 THC (41.2%). Primary motivations for use were its legal status and perceived therapeutic benefits. Males were more likely than females to report Delta-8 THC use (aOR = 1.4, 95% CI 1.2, 1.7). Respondents residing in states with restrictions on sales of Delta-8 THC products had lower odds of Delta-8 THC use (aOR = 0.7, 95% CI 0.57, 0.86).
Findings provide initial insight into the current state of Delta-8 THC use in the US. Given the limited knowledge on use of Delta-8 THC, and considering emergence of reports indicating its harmful effects, there is urgent need for nationally representative data to investigate correlates of Delta-8 THC use (e.g., effectiveness of state-specific restrictions on its products). Such information can guide public-health policy around Delta-8 THC use.
新型大麻素产品的使用最近激增,其主要活性化合物是 Delta-8 四氢大麻酚(Delta-8 THC),是 Delta-9 THC 的异构体。虽然 Delta-8 THC 具有精神活性作用,且可能具有危害性,但人们对其使用知之甚少。我们研究了美国成年大麻使用者中 Delta-8 THC 的社会人口统计学特征、动机和消费模式。
使用大麻的成年在线调查参与者(N=4348)提供了有关 Delta-8 使用情况以及其他特征的信息。我们评估了 Delta-8 THC 使用的社会人口统计学模式和相关因素。回归模型估计了过去 30 天 Delta-8 THC 使用与社会人口统计学和其他特征之间关联的调整后优势比(aOR)和 95%置信区间(CI)。
在过去 30 天使用大麻的人群中,有 16.7%的人报告使用了 Delta-8 THC。最常见的使用方法是吸食浓缩的 Delta-8 THC 制剂(41.2%)。使用的主要动机是其合法地位和被认为的治疗益处。男性比女性更有可能报告使用 Delta-8 THC(aOR=1.4,95%CI 1.2,1.7)。居住在限制销售 Delta-8 THC 产品的州的受访者使用 Delta-8 THC 的可能性较低(aOR=0.7,95%CI 0.57,0.86)。
这些发现初步揭示了美国目前 Delta-8 THC 使用的状况。鉴于对 Delta-8 THC 使用的了解有限,并且考虑到有报告表明其具有危害性,迫切需要进行全国代表性数据调查,以研究 Delta-8 THC 使用的相关因素(例如,对其产品的特定州限制的有效性)。这些信息可以为 Delta-8 THC 使用的公共卫生政策提供指导。